Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 4
2011 2
2012 4
2013 7
2014 7
2015 7
2016 6
2017 3
2018 5
2019 3
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma.
Chan CY, Chiu DK, Yuen VW, Law CT, Wong BP, Thu KL, Cescon DW, Soria-Bretones I, Cheu JW, Lee D, Tse AP, Zhang MS, Tan KV, Ng IO, Khong PL, Yau TC, Bray MR, Mak TW, Wong CC. Chan CY, et al. Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2119514119. doi: 10.1073/pnas.2119514119. Epub 2022 Aug 1. Proc Natl Acad Sci U S A. 2022. PMID: 35914158 Free PMC article.
In response.
Hubaux R, Thu KL, Lam WL, Alex A. Hubaux R, et al. Among authors: thu kl. J Thorac Oncol. 2013 Nov;8(11):e103-4. doi: 10.1097/01.JTO.0000435739.64803.99. J Thorac Oncol. 2013. PMID: 24128723 Free PMC article. No abstract available.
Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity.
Chan CY, Yuen VW, Chiu DK, Goh CC, Thu KL, Cescon DW, Soria-Bretones I, Law CT, Cheu JW, Lee D, Tse AP, Tan KV, Zhang MS, Wong BP, Wong CM, Khong PL, Ng IO, Bray MR, Mak TW, Yau TC, Wong CC. Chan CY, et al. Among authors: thu kl. Hepatology. 2023 Mar 1;77(3):729-744. doi: 10.1002/hep.32461. Epub 2023 Feb 17. Hepatology. 2023. PMID: 35302667
Targeting Mitosis in Cancer: Emerging Strategies.
Dominguez-Brauer C, Thu KL, Mason JM, Blaser H, Bray MR, Mak TW. Dominguez-Brauer C, et al. Among authors: thu kl. Mol Cell. 2015 Nov 19;60(4):524-36. doi: 10.1016/j.molcel.2015.11.006. Mol Cell. 2015. PMID: 26590712 Free article. Review.
ATM-the gene at the moment in non-small cell lung cancer.
Thu KL, Yoon JY. Thu KL, et al. Transl Lung Cancer Res. 2024 Mar 29;13(3):699-705. doi: 10.21037/tlcr-23-853. Epub 2024 Mar 15. Transl Lung Cancer Res. 2024. PMID: 38601449 Free PMC article. No abstract available.
The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER+ breast cancer with mitotic aberrations.
Soria-Bretones I, Thu KL, Silvester J, Cruickshank J, El Ghamrasni S, Ba-Alawi W, Fletcher GC, Kiarash R, Elliott MJ, Chalmers JJ, Elia AC, Cheng A, Rose AAN, Bray MR, Haibe-Kains B, Mak TW, Cescon DW. Soria-Bretones I, et al. Among authors: thu kl. Sci Adv. 2022 Sep 9;8(36):eabq4293. doi: 10.1126/sciadv.abq4293. Epub 2022 Sep 7. Sci Adv. 2022. PMID: 36070391 Free PMC article.
Methylation analysis by DNA immunoprecipitation.
Thu KL, Pikor LA, Kennett JY, Alvarez CE, Lam WL. Thu KL, et al. J Cell Physiol. 2010 Mar;222(3):522-31. doi: 10.1002/jcp.22009. J Cell Physiol. 2010. PMID: 20020444 Review.
Methylated DNA immunoprecipitation.
Thu KL, Vucic EA, Kennett JY, Heryet C, Brown CJ, Lam WL, Wilson IM. Thu KL, et al. J Vis Exp. 2009;(23):935. doi: 10.3791/935. J Vis Exp. 2009. PMID: 19241501 Free PMC article.
Translating cancer 'omics' to improved outcomes.
Vucic EA, Thu KL, Robison K, Rybaczyk LA, Chari R, Alvarez CE, Lam WL. Vucic EA, et al. Among authors: thu kl. Genome Res. 2012 Feb;22(2):188-95. doi: 10.1101/gr.124354.111. Genome Res. 2012. PMID: 22301133 Free PMC article.
52 results